Ocera Therapeutics to Present at Stifel 2014 Healthcare Conference
10 nov. 2014 08h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Therapeutics to Announce Third Quarter 2014 Financial Results
04 nov. 2014 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Therapeutics to Present at 13th Annual BIO Investor Forum
29 sept. 2014 09h00 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Therapeutics Announces Appointment of Steven P. James to Board
18 sept. 2014 16h05 HE
|
Ocera Therapeutics, Inc.
PALO ALTO, Calif., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Ocera Therapeutics to Present at BIO Investor on October 8, 2013
25 sept. 2013 05h10 HE
|
Ocera Therapeutics, Inc.
SAN DIEGO, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that...